Pharmaceutical Industry Upgrading: Chemical API Growth Remains Robust, with a Vast Market Size
Release date:
2018-09-21
As an important component of China’s pharmaceutical industry, the chemical API sector has experienced rapid growth, with both sales revenue and total profits continuing to rise at a steady pace. Through ongoing upgrades, the industry has shifted its product portfolio from mid- to low-end toward mid- to high-end, while R&D capabilities have improved significantly, boding well for sustained future prospects.
The chemical API industry is developing rapidly.
As an important component of China’s pharmaceutical industry, the chemical API sector has experienced rapid growth, with both industry sales revenue and total profits continuing to rise unabated. Through ongoing upgrades, the sector has shifted its product portfolio from mid- to low-end toward mid- to high-end, while R&D capabilities have improved markedly, ensuring a steadily improving outlook.
What is a chemical active pharmaceutical ingredient?
Chemical active pharmaceutical ingredients (APIs) refer to the raw materials used in the manufacture of various dosage forms—namely, medicinal powders, crystals, extracts, and other active constituents obtained through specific preparation processes. These substances are not intended for direct administration to patients. Common preparation methods include chemical synthesis, plant extraction, and biotechnological approaches.
Based on efficacy and intended use, chemical APIs can be classified into anti-infective agents, vitamins, respiratory system medications, and others; based on product value and characteristics, they can be categorized as bulk APIs and specialty APIs.
Bulk APIs refer to traditional chemical APIs that are in high demand, have mature manufacturing processes, and are not subject to patent disputes—such as antibiotics and vitamins—and are closely linked to basic healthcare coverage. Specialty APIs, on the other hand, are raw materials for products whose patents have recently expired; generally speaking, specialty APIs tend to offer relatively higher profit margins.
At present, most Chinese API manufacturers are merely basic raw-material suppliers, relying on scale and low costs to capture market share, with relatively weak competitiveness in specialty APIs. As labor costs rise and environmental pressures intensify, chemical APIs are finding it increasingly difficult to maintain their price advantage; moving toward mid- to high-end APIs is the prevailing trend for the future.
In the production processes of chemical APIs, the pollutants generated are diverse, highly toxic, corrosive, and difficult to render harmless, making this sector a key focus of environmental remediation. Consequently, amid increasing environmental investment, chemical API manufacturers face substantial pressure, rendering transformation and upgrading an inevitable imperative.
According to data from the “China API Industry Production, Sales, Demand, and Investment Forecast Analysis Report” published by the Qianzhan Industry Research Institute, in 2014 the chemical API market was valued at RMB 424.035 billion, up 11.35% year on year. Over the next five years, the market is expected to grow at a compound annual growth rate of 9.5%, with the market size projected to exceed RMB 700 billion by 2020.
Prospects for Chemical Active Pharmaceutical Ingredients
Overall, the outlook for chemical APIs is promising, and following restructuring and upgrading, they are expected to maintain a relatively rapid growth rate. Looking ahead, the chemical API industry will need to further enhance the efficient utilization of production capacity, expand the scale of the sector, and increase the export of finished dosage forms to achieve transformation and upgrading.
Related News
Leave a Message Online
Consultation Service Hotline
Address: No. 509, East Lin Road, Bio-Industrial Park, High-tech Zone, Yichang City, Hubei Province, China
International Marketing Department
Contact: Vivian Guo
Email: Vivian.guo@tianrenpharm.com
Phone: 86-15997560212
WhatsApp: +86-15997560212
Website Development:China Enterprise Dynamics Yichang right of privacy
This website supports both IPv4 and IPv6 bidirectional access.